arrow
P

Pierre Sabouret

Sorbonne University
H指数:24
被引数:3,188

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Routine versus deferred percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a frequentist and Bayesian meta-analysis of randomized trials with trial sequential analysis

经导管主动脉瓣植入术患者中常规与延迟经皮冠状动脉干预的比较:一项随机试验的频数和贝叶斯Meta分析及试验序贯分析

2026-09-220
OAAI
Healthcare Professional Awareness and Use of Inflammation-Based Risk Assessment in ASCVD: The CARDIO-INFLAME Survey

医疗专业人员对炎症为基础的风险评估在动脉粥样硬化性心血管疾病中的认知与使用:CARDIO-INFLAME调查

2026-08-290
OAAI
Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies

动脉粥样硬化血管床中的最佳抗血栓方案:面向机制与风险导向的策略

2026-04-060
OAAI
Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis

缺血性卒中后合并心房颤动和动脉粥样硬化性心血管疾病患者的最佳抗栓治疗方案:一项频数网络Meta分析

2026-03-030
OAAI
Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary Syndrome

脂蛋白(a)对急性冠状动脉综合征后残余心血管风险的影响

2026-02-270
OAAI
Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysis

稳定型冠状动脉疾病且具有抗凝指征的患者中,单用抗凝剂与联用抗血小板疗法的效果比较:一项含试验序贯分析的荟萃分析

2026-01-012
PRE
The risk of cardiovascular death in systemic immune-mediated diseases: A systematic review and meta-analysis

系统性免疫介导性疾病中心血管死亡的风险:一项系统评价和荟萃分析

2025-12-070
OAAI
Bundle branch block and pacemaker Rhythm as independent predictors of mortality in critically ill cardiac patients

束支传导阻滞和起搏器心律作为危重心脏病患者死亡率的独立预测因子

2025-10-240
PRE
Kinetics of High-Sensitive Cardiac Troponin I in Patients with ST-Segment Elevation Myocardial Infarction and Non-ST Segment Elevation Myocardial Infarction

高敏心肌肌钙蛋白I在ST段抬高型心肌梗死和非ST段抬高型心肌梗死患者中的动力学

2025-09-300
OAAI
Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data

减量剂量与全剂量直接口服抗凝剂用于静脉血栓栓塞症延长治疗的疗效与安全性:一项结合试验序贯分析和重建时间-事件数据的荟萃分析

2025-09-110
OAAI